Humulin n and Swallowing difficulty - a phase IV clinical study of FDA data

Summary:

Swallowing difficulty is reported as a side effect among people who take Humulin n (insulin susp isophane recombinant human), especially for people who are male, 60+ old, have been taking the drug for 10+ years also take Humulin R, and have Type 2 diabetes.

The phase IV clinical study analyzes which people have Swallowing difficulty when taking Humulin n. It is created by eHealthMe based on reports of 9,819 people who have side effects when taking Humulin n from the FDA, and is updated regularly.

What is Humulin n?

Humulin n has active ingredients of insulin susp isophane recombinant human. It is often used in diabetes. eHealthMe is studying from 9,878 Humulin n users. Check the latest studies of Humulin n.

What is Swallowing difficulty?

Swallowing difficulty is found to be associated with 2,401 drugs and 3,349 conditions by eHealthMe. Check the latest studies of Swallowing difficulty.

On Jul, 11, 2026

9,819 people reported to have side effects when taking Humulin n.
Among them, 22 people (0.22%) have Swallowing difficulty.

Could Humulin n cause Swallowing difficulty?

Among these 22 people:

How long have people been on Humulin n when they have Swallowing difficulty? *

What is the gender of people who have Swallowing difficulty when taking Humulin n? *

female: 45.45 %
male: 54.55 %

What is the age of people who have Swallowing difficulty when taking Humulin n? *

What are other drugs people take besides Humulin n? *

What are other side effects people have besides Swallowing difficulty? *

Blood Glucose Increased: 6 people, 27.27%
Dizziness: 4 people, 18.18%
Dyspnea (difficult or laboured breathing): 4 people, 18.18%
Fall: 4 people, 18.18%
Visual Impairment: 3 people, 13.64%
Urticaria (rash of round, red welts on the skin that itch intensely): 3 people, 13.64%
Lip Swelling: 2 people, 9.09%
Pain: 2 people, 9.09%
Pneumonia: 2 people, 9.09%
Presyncope: 2 people, 9.09%

What are the existing conditions these people have? *

Type 2 Diabetes: 3 people, 13.64%
Parkinson's Disease: 2 people, 9.09%
High Blood Cholesterol: 1 person, 4.55%
Angioedema (rapid swelling of the dermis): 1 person, 4.55%
Arthritis (form of joint disorder that involves inflammation of one or more joints): 1 person, 4.55%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 1 person, 4.55%
Blood Potassium Decreased: 1 person, 4.55%
Cardiac Failure Congestive: 1 person, 4.55%
Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 1 person, 4.55%
Emphysema (chronic respiratory disease - over inflation of the air sacs (alveoli) in the lungs): 1 person, 4.55%

* Approximation only. Some reports may have incomplete information.

Do you take Humulin n and have Swallowing difficulty?

- Check whether Swallowing difficulty is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Humulin n:

Humulin n (9,878 reports)

Swallowing difficulty treatments and more:

Swallowing difficulty (112,312 reports)

How severe was Swallowing difficulty and when was it recovered:

Swallowing difficulty in Humulin n

Expand to all the drugs that have ingredients of insulin susp isophane recombinant human:

Swallowing difficulty and drugs with ingredients of insulin susp isophane recombinant human

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Humulin n:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Swallowing difficulty:

Swallowing difficulty (2,401 drugs)

Browse all the conditions that are associated with Swallowing difficulty:

Swallowing difficulty (3,349 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on insulin susp isophane recombinant human (the active ingredients of Humulin n) and Humulin n (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.